## ALGM: Allegro MicroSystems, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.25 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($26.08)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- FMR, LLC: 14.8% (+0.8%)
- Capital Research Glo: 9.1% (+5.8%)
- JPMORGAN CHASE & CO: 8.4% (+93.0%)
- Vanguard Group Inc: 7.7% (+0.6%)
- Blackrock Inc.: 6.2% (-3.5%)

### Key Risks

1. Elevated short interest (10.5%): bears positioning against stock.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.25 indicates undervaluation relative to growth. Forward P/E 29.3x attractive for 85% earnings growth. Balance sheet: strong liquidity (3.9x), low leverage (D/E 0.46). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.3B |
| Beta | 1.62 |
| 52W Range | $16.38 - $38.45 |
| Short Interest | 10.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.25 |
| Forward P/E | 29.3 |
| Current P/E | 54.3 |
| YoY Growth | 85.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 10.6% to 6.3% (-4.2% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 82nd percentile. MRS_5 (-1.6%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 8.5% shows strong absolute momentum above own 20MA. Outperforming sector by 5.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.35% (CS: 83) | Strong |
| RSI_14 | 56.5 | Neutral |
| MACD Histogram | 0.48 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 1.012x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $28.48
- **Stop Loss:** $26.08 (8.4% risk)
- **Target:** $33.28 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 575
- **Position Value:** $16,376.00
- **Portfolio %:** 16.38%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-29 (Est: $0.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.12 | $0.13 | +5.4% |
| 2025Q2 | $0.08 | $0.09 | +6.5% |
| 2025Q1 | $0.05 | $0.06 | +19.6% |
| 2024Q4 | $0.06 | $0.07 | +9.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*